GRANTS. Annika Rosengren and Bright Nwaru are to receive SEK 13 million each for their research projects in the Swedish Research Council’s register-based research call. The money will generate new knowledge of several major common diseases, including cardiovascular diseases, diabetes, asthma, and chronic obstructive pulmonary disease (COPD). The award means that Institute of Medicine will receive a quarter of the total grant amount, SEK 102 million, through the national call.…
How blood sugar levels affect risks in type 1 diabetes
NEW STUDY. A major new study on the association between blood glucose levels and risks of organ impairment in people with type 1 diabetes can make a vital contribution to diabetes care, in the researchers’ view. The Swedish study now published in BMJ (British Medical Journal) covers more than 10,000 adults and children with type 1 diabetes. Using the Swedish Diabetes Register, the researchers have been able to monitor the…
More cancer cases among women with sleep apnea
NEW STUDY. Women with severe sleep apnea appear to be at an elevated risk of getting cancer, a study shows. No causal relationship is demonstrated, but the link between nocturnal hypoxia in women and higher cancer risk is still clear. “It’s reasonable to assume that sleep apnea is a risk factor for cancer, or that both conditions have common risk factors, such as overweight. On the other hand, it is…
Post-bypass survival linked to civil status and class
NEW STUDY. Civil status, education, and income are factors shown to be clearly associated with duration of survival after a bypass operation. A postoperative patient aged 60 with a spouse or cohabiting partner, high educational attainment, and high income has a median life expectancy five years longer than a corresponding person with no live-in partner, a low education level, and low income. “Our study shows that your risk of dying…
Low adherence to cholesterol-lowering medication also protective in type 2 diabetes
DOCTORAL THESIS. Type 2 diabetes patients’ risk of cardiovascular disease and death decreases if they actually take the cholesterol-lowering drugs as prescribed. However, research shows that the risk is also reduced if they do not take the full dosage. “These results are important and useful for patients and healthcare providers alike, to try and motivate patients to follow the recommended treatment even if they forget to take their pills from…